(ELF) ELF Beauty - Overview
Cosmetics, Skincare, Eye, Lip, Face
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 68.3% |
| Relative Tail Risk | -13.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.04 |
| Alpha | -44.33 |
| Character TTM | |
|---|---|
| Beta | 1.627 |
| Beta Downside | 1.452 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.09% |
| CAGR/Max DD | 0.17 |
Description: ELF ELF Beauty January 08, 2026
e.l.f. Beauty, Inc. (NYSE:ELF) is a U.S.-based personal-care company that markets cosmetics and skin-care products under the e.l.f. Cosmetics, e.l.f. Skin, Well People, Naturium, and Keys Soulcare brands. Its portfolio spans eye, lip, face, “paw” (nail), and skin-care categories, and the firm distributes through both traditional retail partners and a growing direct-to-consumer (DTC) e-commerce channel.
Since its 2004 founding and the 2016 rebranding from J.A. Cosmetics Holdings, ELF has leveraged a value-priced, “clean-beauty” positioning to capture price-sensitive consumers. In FY 2023 the company reported net revenue of roughly $1.5 billion, representing a 13 % year-over-year increase, with DTC sales accounting for about 40 % of total revenue-an indicator of accelerating online penetration. Gross margins hovered near 78 %, reflecting a lean product mix and efficient supply-chain management.
Key macro drivers for ELF include the continued shift toward affordable, cruelty-free cosmetics, strong e-commerce growth in the personal-care sector, and resilient consumer spending on “self-care” even in a higher-interest-rate environment. For a deeper quantitative dive, the ValueRay platform provides a granular breakdown of ELF’s valuation multiples and forward cash-flow projections.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 81.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.29 > 1.0 |
| NWC/Revenue: 32.14% < 20% (prev 19.97%; Δ 12.17% < -1%) |
| CFO/TA 0.07 > 3% & CFO 172.0m > Net Income 81.8m |
| Net Debt (723.4m) to EBITDA (190.3m): 3.80 < 3 |
| Current Ratio: 2.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.6m) vs 12m ago 1.90% < -2% |
| Gross Margin: 70.27% > 18% (prev 0.71%; Δ 6956 % > 0.5%) |
| Asset Turnover: 77.94% > 50% (prev 98.43%; Δ -20.50% > 0%) |
| Interest Coverage Ratio: 7.62 > 6 (EBITDA TTM 190.3m / Interest Expense TTM 18.2m) |
Altman Z'' 1.45
| A: 0.19 (Total Current Assets 707.2m - Total Current Liabilities 261.9m) / Total Assets 2.32b |
| B: -0.06 (Retained Earnings -145.9m / Total Assets 2.32b) |
| C: 0.08 (EBIT TTM 138.4m / Avg Total Assets 1.78b) |
| D: -0.12 (Book Value of Equity -144.4m / Total Liabilities 1.18b) |
| Altman-Z'' Score: 1.45 = BB |
Beneish M -2.87
| DSRI: 0.93 (Receivables 154.7m/146.6m, Revenue 1.39b/1.22b) |
| GMI: 1.01 (GM 70.27% / 71.00%) |
| AQI: 1.25 (AQ_t 0.68 / AQ_t-1 0.54) |
| SGI: 1.14 (Revenue 1.39b / 1.22b) |
| TATA: -0.04 (NI 81.8m - CFO 172.0m) / TA 2.32b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of ELF shares?
Over the past week, the price has changed by -7.45%, over one month by +6.99%, over three months by -35.47% and over the past year by -19.95%.
Is ELF a buy, sell or hold?
- StrongBuy: 9
- Buy: 3
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ELF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 112.4 | 32.3% |
| Analysts Target Price | 112.4 | 32.3% |
| ValueRay Target Price | 90.4 | 6.4% |
ELF Fundamental Data Overview January 26, 2026
P/E Forward = 27.248
P/S = 4.0526
P/B = 4.9301
P/EG = 2.03
Revenue TTM = 1.39b USD
EBIT TTM = 138.4m USD
EBITDA TTM = 190.3m USD
Long Term Debt = 831.6m USD (from longTermDebt, last quarter)
Short Term Debt = 30.6m USD (from shortTermDebt, last quarter)
Debt = 917.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 723.4m USD (from netDebt column, last quarter)
Enterprise Value = 6.34b USD (5.62b + Debt 917.8m - CCE 194.4m)
Interest Coverage Ratio = 7.62 (Ebit TTM 138.4m / Interest Expense TTM 18.2m)
EV/FCF = 44.64x (Enterprise Value 6.34b / FCF TTM 142.0m)
FCF Yield = 2.24% (FCF TTM 142.0m / Enterprise Value 6.34b)
FCF Margin = 10.25% (FCF TTM 142.0m / Revenue TTM 1.39b)
Net Margin = 5.90% (Net Income TTM 81.8m / Revenue TTM 1.39b)
Gross Margin = 70.27% ((Revenue TTM 1.39b - Cost of Revenue TTM 411.9m) / Revenue TTM)
Gross Margin QoQ = 69.45% (prev 69.13%)
Tobins Q-Ratio = 2.73 (Enterprise Value 6.34b / Total Assets 2.32b)
Interest Expense / Debt = 1.00% (Interest Expense 9.15m / Debt 917.8m)
Taxrate = 22.96% (33.4m / 145.5m)
NOPAT = 106.7m (EBIT 138.4m * (1 - 22.96%))
Current Ratio = 2.70 (Total Current Assets 707.2m / Total Current Liabilities 261.9m)
Debt / Equity = 0.81 (Debt 917.8m / totalStockholderEquity, last quarter 1.14b)
Debt / EBITDA = 3.80 (Net Debt 723.4m / EBITDA 190.3m)
Debt / FCF = 5.10 (Net Debt 723.4m / FCF TTM 142.0m)
Total Stockholder Equity = 868.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.60% (Net Income 81.8m / Total Assets 2.32b)
RoE = 9.43% (Net Income TTM 81.8m / Total Stockholder Equity 868.0m)
RoCE = 8.15% (EBIT 138.4m / Capital Employed (Equity 868.0m + L.T.Debt 831.6m))
RoIC = 8.38% (NOPAT 106.7m / Invested Capital 1.27b)
WACC = 10.34% (E(5.62b)/V(6.53b) * Re(11.91%) + D(917.8m)/V(6.53b) * Rd(1.00%) * (1-Tc(0.23)))
Discount Rate = 11.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.34%
[DCF Debug] Terminal Value 74.03% ; FCFF base≈94.3m ; Y1≈116.3m ; Y5≈198.1m
Fair Price DCF = 25.78 (EV 2.26b - Net Debt 723.4m = Equity 1.54b / Shares 59.6m; r=10.34% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 25.34 | EPS CAGR: -24.23% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.17 | Revenue CAGR: 39.72% | SUE: -2.01 | # QB: 0
EPS current Year (2026-03-31): EPS=2.86 | Chg30d=+0.010 | Revisions Net=-1 | Growth EPS=-15.7% | Growth Revenue=+19.3%
EPS next Year (2027-03-31): EPS=3.49 | Chg30d=-0.035 | Revisions Net=+0 | Growth EPS=+22.3% | Growth Revenue=+16.6%